Historic Phase 3 Microbiota Trial for C Diff Treatment Completes Enrollment
RBX2660 from Rebiotix will be assessed in a randomized study involving 300 patients.
Flu Cases Reach 13 Million in the US, CDC Reports
New data for the 2019-2020 season shows the virus is at a high activity, but disease severity is moderate.
FDA Approves Cefiderocol for cUTI
In the pivotal assessment, three-quarters of patients who received cefiderocol had resolution of symptoms and eradication of the bacteria 1 week after completing treatment, versus 54.6% of patients who received an alternative antibiotic.
Delafloxacin Receives FDA Approval for Community-Acquired Bacterial Pneumonia
The supplemental new drug application was approved based on results of a phase 3 trial in which IV-to-oral delafloxacin met the primary end point of statistical non-inferiority to moxifloxacin.
FDA Approves Baloxavir Marboxil for Flu Complications
Xofluza is currently being evaluated in a phase 3 development program for the reduced transmission of flu from an infected person to healthy people.
National Perception of Dementia on World Alzheimers Day
A panel discussion on a growing public concern over our ability to treat and prevent dementia.
The Future in Managing Alzheimer Disease
Considerations for improving upon the diagnosis and management of Alzheimer disease.
Upcoming Studies for the Treatment of Alzheimer Disease
An overview of exciting, upcoming therapies that may be of interest for the treatment of Alzheimer disease.
Emerging Agents for the Treatment of Alzheimer Disease
Experts discuss the status of clinical trials that explore various monoclonal antibody therapies and BACE inhibitors for the treatment of Alzheimer disease.
BACE Inhibitors and Antibodies in Alzheimer Disease
The rationale for investigating monoclonal antibodies and BACE inhibitors for the treatment of patients with Alzheimer disease.
Neurology Congress to Host Expert Talk on Stroke Care Issues
The International Congress on the Future of Neurology will take place this Fall in New York City, convening experts in neurology to discuss the latest data and best practices to better inform clinical decision-making.
A Team-Based Approach to Alzheimer Disease
Drs. Alireza Atri and Ronald C. Petersen remark on the important roles a community neurologist, as well as other members of a patient’s health care team, can play in the management of Alzheimer disease.
Improving Care in Alzheimer Disease
The role of clinical trials and the importance of counseling patients on trial enrollment and lifestyle interventions in the management of Alzheimer disease.
Treating Alzheimer Disease: Unmet Needs
Expert clinicians highlight current unmet needs surrounding the treatment of Alzheimer disease.
Lessons in Alzheimer Disease
Moving forward following failed studies in Alzheimer disease and improving how the condition is managed in the future.
The Mechanisms of Neurodegeneration in Alzheimer Disease
An in-depth review of mechanisms linked to the pathogenesis of Alzheimer disease, including amyloid and tau.
The Role of Genetics in Alzheimer Disease
Ronald C. Petersen, MD, PhD, discusses the relationship between genetics and the risk for developing Alzheimer disease, as well as highlights efforts of the Generation Program.
A Historical Perspective of Alzheimer Disease
How the thought of AD has changed to interpret the disease's pathology, and why that has benefitted clinicians.
The Top 10 Stories of August
Catch up on or relive the biggest headlines in healthcare of the past month.
The 10 Countries with the Most Physicians Per Capita
With all the talk about a looming physician shortage in the US, it's instructive to see where the US falls in terms of physicians per capita.
2 Commerce Drive Cranbury, NJ 08512